GEAT, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 454
EU - Europa 261
AS - Asia 62
OC - Oceania 2
SA - Sud America 1
Totale 780
Nazione #
US - Stati Uniti d'America 453
IE - Irlanda 66
CN - Cina 58
SE - Svezia 53
FR - Francia 46
IT - Italia 30
DE - Germania 26
GB - Regno Unito 23
FI - Finlandia 8
AU - Australia 2
CH - Svizzera 2
UA - Ucraina 2
BE - Belgio 1
BZ - Belize 1
DK - Danimarca 1
EC - Ecuador 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
LU - Lussemburgo 1
NL - Olanda 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 780
Città #
Chandler 111
Ashburn 79
Dublin 61
Houston 53
Southend 22
Jacksonville 16
Lawrence 16
Princeton 16
Beijing 13
Sindelfingen 13
Wilmington 13
New York 12
Washington 10
Helsinki 6
Verona 6
Ann Arbor 5
Esslingen am Neckar 5
Chieti 4
Falls Church 4
Jinan 4
Redmond 4
Seattle 4
Shenyang 4
Changsha 3
Redwood City 3
Sesto San Giovanni 3
Tianjin 3
Baoding 2
Bologna 2
Canberra 2
Dongguan 2
Florence 2
Fuzhou 2
Guangzhou 2
Hangzhou 2
Lappeenranta 2
Palermo 2
Zhengzhou 2
Adliswil 1
Amsterdam 1
Belize City 1
Brussels 1
Copenhagen 1
Edinburgh 1
Elmhurst 1
Fairfield 1
Frankfurt am Main 1
Fremont 1
Grafing 1
Gunzenhausen 1
Hong Kong 1
Jerusalem 1
Kronberg 1
Lanzhou 1
Los Angeles 1
Luxembourg 1
Miami 1
Nanjing 1
Portoviejo 1
Riva 1
Rome 1
Saint Petersburg 1
San Diego 1
Taizhou 1
Tokyo 1
Totale 542
Nome #
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 99
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 58
Bleomycin-induced Flagellate Dermatitis: a Case Report 54
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 48
Relapse of psoriatic arthritis in patients with active psoriasis switched from tumour necrosis factor-α to interleukin-17A inhibitor 43
Assessing patients' characteristics and treatment patterns among children with atopic dermatitis 42
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 41
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 40
Place of apremilast in the real-life treatment of patients with plaque psoriasis 39
Increased red blood cell distribution width in patients with plaque psoriasis 39
Characteristics associated with clinical response to Comano thermal spring water balneotherapy in pediatric patients with atopic dermatitis 36
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 36
A case of genital primary syphilis with superimposed impetigo 35
A case of kerion celsi caused by Trichophyton tonsurans 35
A case of porokeratosis with predominant follicular involvement 35
An intriguing genital eruption in a traveler returning from Philippines 30
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 26
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 20
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 18
Pyoderma gangrenosum associated with pseudo-PelgerHuët anomaly in a patient with idiopathic myelofibrosis 17
Recurrent cutaneous eosinophilic vasculitis characterized by annular purpuric lesions: A case report 11
Price variability of TNF-α inhibitor biosimilars among European countries 7
Totale 809
Categoria #
all - tutte 3.915
article - articoli 3.915
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 2 0 11 6 4 39 3 0 0 0 0 3
2020/202191 29 7 1 9 10 10 10 0 2 5 6 2
2021/202290 4 7 0 1 16 2 4 6 9 7 8 26
2022/2023351 23 25 35 49 40 79 12 26 47 6 8 1
2023/2024209 9 23 24 27 26 63 16 16 2 3 0 0
Totale 809